Nexus Pharmaceuticals
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Illinois, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
400 Knightsbridge Pkwy, Lincolnshire, Il...Phone Number
(847) 996-3790Website
www.nexuspharma.netRevenue
$67.2 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Nexus Pharmaceuticals
Nexus Pharmaceuticals is a US-based, family-owned, minority-led pharmaceutical manufacturer that has been a pioneer in the generic and specialty injectable drug industry since 2003. The company focuses on fulfilling critical unmet medical needs by providing dependable life-saving treatment options. Their robust pipeline includes several first-to-market FDA-approved generic drugs across various therapeutic categories, including cardiovascular, oncology, antispasmodic, and anti-epileptic. Nexus Pharmaceuticals aims to connect molecules to medicine, ensuring that essential drugs are available when and where they are needed most.Explore more
Nexus Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Nexus Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Nexus Pharmaceuticals launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Nexus Pharmaceuticals had a recent Job posting/layoffs
Check out if Nexus Pharmaceuticals is spiking on competitors!
Nexus Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Nexus Pharmaceuticals recently announced quarterly report
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Nexus Pharmaceuticals
Check if Nexus Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Nexus Pharmaceuticals has new funding data
Recommended Actions
Find VP level buyers at Nexus Pharmaceuticals
Find 3 more new buyers
Compare Similar Companies to Nexus Pharmaceuticals
Compare insights from companies similar to Nexus Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Nexus Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Nexus Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Nexus Pharmaceuticals.
Nexus Pharmaceuticals financials insights
Gather financial insights about Nexus Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$1M
Nexus Pharmaceuticals Tech Stack
A closer look at the technologies used by Nexus Pharmaceuticals
See more technologies
Most Recent Scoops
Open Position
Hiring Plans
Nexus Pharmaceuticals has more open roles in Operations than it has had at any time in the past 12 months.
Executive Move
Board of Directors
Executive Move
Board of Directors
Project
Legal Affairs, Facilities Management
Nexus Pharmaceuticals News & Media
Nexus Pharmaceuticals Launches Methylene Blue Injection
LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--Nexus Pharmaceuticals, LLC proudly announces the launch of Methylene Blue Injection, USP. Methylene Blue Injection is indicated for the treatment of methemoglobinemia – a condition that affects the blood’s ability to carry oxygen. “The launch represents a vital addition to Nexus’ growing portfolio of life-saving and difficult-to-manufacture medications,” said Usman Ahmed, CEO of Nexus Pharmaceuticals. “Methylene Blue is a critical drug in emergency care, andNexus Pharmaceuticals Launches Baclofen Injection Refill Kit
LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--Nexus Pharmaceuticals, LLC announces the launch of their Baclofen Injection Refill Kit. Nexus’ kit will be the only one on the market that offers a vial presentation. “We are proud to be supplying healthcare systems with not only a life-changing drug, such as Baclofen, but also with a convenience kit to deliver the medication in a safe, accommodating, and timely fashion,” says Omair Ahmed, Chief Operating Officer at Nexus. “This kit will easeNexus Pharmaceuticals Launches Fluorescein 2 mL
LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--Nexus Pharmaceuticals, LLC is expanding their Fluorescein dosage options to include Fluorescein Injection, USP 25% in a 2 mL vial alongside Fluorescein Injection, USP 10% in a 5 mL vial. Nexus is committed to enhancing the availability of Fluorescein across the optometry market. Fluorescein 2 mL and 5 mL are available in cartons of ten. Order your supply of 2 mL Fluorescein Injection, USP 25% directly through your Wholesalers or from Customer ServiceNexus Pharmaceuticals Launches Tranexamic Acid
LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--Nexus Pharmaceuticals, LLC announced the launch of Tranexamic Acid. This milestone is another step for Nexus in its mission to provide life-saving medication to those who need it most. “We are very excited to be adding Tranexamic Acid to our product portfolio,” says Vince LoPiccolo, Vice President of Sales at Nexus. “Antifibrinolytic Agents, such as Tranexamic Acid, are crucial to have available in operating rooms and we are proud to contribute to the
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Nexus Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Nexus Pharmaceuticals is a US-based, family-owned, minority-led pharmaceutical manufacturer that has been a pioneer in the generic and specialty injectable drug industry since 2003. The company focuses on fulfilling critical unmet medical needs by providing dependable life-saving treatment options. Their robust pipeline includes several first-to-ma... Read More
